Evidence map›Paper›PMID 37079217›Full record

ArticleGeroScience2023

Transfer learning in a biomaterial fibrosis model identifies in vivo senescence heterogeneity and contributions to vascularization and matrix production across species and diverse pathologies.

Christopher Cherry, James I Andorko, Kavita Krishnan, Joscelyn C Mejías, Helen Hieu Nguyen, Katlin B Stivers, Elise F Gray-Gaillard, Anna Ruta, Jin Han, Naomi Hamada and 16 more

Open access · greenAbstract read
In one paragraph

Article in GeroScience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
10.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 58 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 8 institutions in 2 countries.

Christopher CherryTranslational Tissue Engineering Center, Wilmer Eye Institute and the Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
James I AndorkoTranslational Tissue Engineering Center, Wilmer Eye Institute and the Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Kavita KrishnanTranslational Tissue Engineering Center, Wilmer Eye Institute and the Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Joscelyn C MejíasTranslational Tissue Engineering Center, Wilmer Eye Institute and the Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Helen Hieu NguyenTranslational Tissue Engineering Center, Wilmer Eye Institute and the Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Katlin B StiversTranslational Tissue Engineering Center, Wilmer Eye Institute and the Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Elise F Gray-GaillardTranslational Tissue Engineering Center, Wilmer Eye Institute and the Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Anna RutaTranslational Tissue Engineering Center, Wilmer Eye Institute and the Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Jin HanTranslational Tissue Engineering Center, Wilmer Eye Institute and the Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Naomi HamadaDepartment of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA.
Masakazu HamadaDepartment of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA.
Ines SturmlechnerDepartment of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA.
Shawn TrewarthaDepartment of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA.
John H MichelTranslational Tissue Engineering Center, Wilmer Eye Institute and the Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Locke Davenport HuyerTranslational Tissue Engineering Center, Wilmer Eye Institute and the Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Matthew T WolfLaboratory of Cancer Immunometabolism, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA.
Ada J TamDepartment of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Alexis N PeñaTranslational Tissue Engineering Center, Wilmer Eye Institute and the Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Shilpa KeerthivasanTumor Microenvironment Thematic Research Center, Bristol Myers Squibb, San Francisco, CA, USA.
Claude Jordan Le SauxDepartment of Medicine, University of California, San Francisco, San Francisco, CA, USA.
Elana J FertigDepartment of Biomedical Engineering and Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Darren J BakerDepartment of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA.
Franck HousseauBloomberg~Kimmel Institute for Cancer Immunotherapy and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Jan M van DeursenDepartment of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, USA.
Drew M PardollBloomberg~Kimmel Institute for Cancer Immunotherapy and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Jennifer H ElisseeffTranslational Tissue Engineering Center, Wilmer Eye Institute and the Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA. jhe@jhu.edu.ORCID 0000-0002-5066-1996
Johns Hopkins University · USBloomberg (United States) · USMayo Clinic in Florida · USMayo Clinic in Arizona · USBristol-Myers Squibb (United States) · USNational Cancer Institute · USUniversity Medical Center Groningen · NLUniversity of California, San Francisco · US

Funding

Medical Scientist Training ProgramT32GM136577 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI ANDREA L COX · 2020 to 2026
$13.4M
Cancer Biomaterials EngineeringZIABC012021 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI WOLF, MATTHEW · 2020 to 2025
$6.7M
JHU-Mayo-NIA Murine Senescence Mapping Program (JMN-MSMP)U54AG079779 · NIA · JOHNS HOPKINS UNIVERSITY · PI JENNIFER H ELISSEEFF · 2022 to 2026
$6.4M
Biomaterials-directed regenerative immunotherapiesDP1AR076959 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI ELISSEEFF, JENNIFER H · 2019 to 2023
$5.7M
Translational Aging Research Training ProgramT32AG058527 · NIA · JOHNS HOPKINS UNIVERSITY · PI Peter M. Abadir, Esther Seunghee Oh · 2018 to 2026
$4.0M
T32: Predoctoral and Postdoctoral Training Program in Nanotechnology for Cancer ResearchT32CA153952 · NCI · JOHNS HOPKINS UNIVERSITY · PI Denis Wirtz · 2015 to 2026
$3.5M
Cellular senescence in aging and age-related disease (Supplement application)R01AG057493 · NIA · MAYO CLINIC ROCHESTER · PI BRAM, RICHARD J · 2018 to 2022
$1.9M
Single-cell and imaging data integration software to spatially resolve the tumor microenvironmentU01CA253403 · NCI · JOHNS HOPKINS UNIVERSITY · PI FERTIG, ELANA · 2020 to 2022
$1.2M
NCI NIH HHS T32 CA153952NCI NIH HHS U01 CA253403NCI NIH HHS U01CA253403NIAMS NIH HHS DP1 AR076959NIA NIH HHS R01 AG057493NIA NIH HHS T32 AG058527NIA NIH HHS U54 AG079779NIGMS NIH HHS T32 GM136577
6 · The paper itself

Abstract

Cellular senescence is a state of permanent growth arrest that plays an important role in wound healing, tissue fibrosis, and tumor suppression. Despite senescent cells' (SnCs) pathological role and therapeutic interest, their phenotype in vivo remains poorly defined. Here, we developed an in vivo-derived senescence signature (SenSig) using a foreign body response-driven fibrosis model in a p16-CreER

Indexed as

AgingCellular SenescenceAnimalsFibroblastsHumansMachine LearningMicePhenotypeFibrosisRNA sequencingSenescence

Identifiers

PMID37079217
PMCPMC10651581
OpenAlexW4366462717

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.